Exercise Preconditioning to Protect Against Dialysis-induced Cardiac Injury

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-79
SponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

About this trial

The goal of this study is to determine what happens to the heart muscle contraction when people cycle before their hemodialysis treatment. Will pre-dialysis exercise protect the heart from a decrease in pumping of the heart muscle (called stunning) that can happen during hemodialysis. We will study whether pre-dialysis exercise decreases heart stunning, decreases the number and severity of symptoms commonly associated with hemodialysis, and other outcomes

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

must be on chronic hemodialysis for at least 3 months

age 18 years or older

willing and able to provide informed consent

assessed to be safe and able to exercise by unit HD Nephrologist

Disqualifiers

regular vigorous exercise outside of hemodialysis

over 79 years of age

intradialytic exercise < 3 months

poor echogenicity

Trial design

Design model

Crossover

Treatments tested in this trial

  • Intradialytic Cycling

    Other intervention

    The impact of interdialytic exercise on cardio protection during HD has never been studied. This approach may enhance cardiovascular benefits and overall physical fitness, thereby contributing to better health outcomes in individuals undergoing HD.

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: Randomization Order 1Experimental treatment 1 intervention
Group B: Randomization Order 2Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Change in the number of left ventricular segments undergoing a greater than 20% reduction in longitudinal strain as detected by echocardiogram

An echocardiogram will be completed pre-hemodialysis (HD) treatment and at peak hemodynamic stress (30 min before the end of HD treatment) at each of the four study sessions. Images will be captured in the left lateral position and standard apical 4, 2, and 3 chamber views will be recorded for analysis using automated speckle-tracking software (EchoPac, GE Healthcare)

Time frame
week 1 to week 4

Secondary outcomes

1

Evaluate potential targets of preconditioning by exercise-induced cardio protection by focusing on hemodynamics (Blood Pressure)

Systolic blood pressure (SBP), Diastolic blood pressure (DBP) and mean arterial pressure (MAP) will be measured using an automated blood pressure monitor integrated into the dialysis machine. Values will be monitored throughout each study.

Time frame
week 1 to week 4
2

Evaluate potential targets of preconditioning by exercise-induced cardio protection focusing on hemodynamics (CV Insight Monitoring),

The CV Insight contact device is a non-invasive continuous hemodynamic real time monitoring system used to assess cardiovascular and respiratory status using percutaneous photoplethysmography. The device will be attached to the right of the patient's forehead midline, approximately 2.5 cm above the level of the nose pre-dialysis and will remain intact until the patient is disconnected from the dialysis machine at each study session. Once attached, baseline recording will be obtained, and hemodynamic data will be continuously captured.

Time frame
week 1 to week 4
3

Evaluate potential targets of preconditioning by exercise-induced cardioprotection, focusing on hemodynamics (Finapres)

The Finometer utilizes a finger-cuff method to detect beat-to-beat changes in digital arterial diameter using an infrared photoplethysmography. The time-averaged data is subsequently downloaded to a computer-based analysis program for analysis. The finger-cuff will be placed on the participant's index finger at each study visit and will remain in place throughout the entire study visit

Time frame
week 1 to week 4
4

Evaluate potential targets of preconditioning by exercise-induced cardio protection, focusing on blood markers

Blood samples will be collected from the participants dialysis access. Before HD and at peak-stress of each study session, will be collected for biochemistry, proteomic analysis and translational approach.

Time frame
week 1 to week 4

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.